0A2V.LSE Sanofi

Healthcare Drug Manufacturers - General London Exchange
46.05 USD
Close of Nov 3, 2026
39.19 47.81
Market cap
USD 112B
P/E
16.0x
P/B
1.30x
ROE
5.7%
Dividend yield
3.44%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0A2V.LSE undervalued?

Graham number
Price46.05
Graham value47.84
Discount3.7%

0A2V.LSE trades 3.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sanofi fundamental analysis

No fundamental analysis for Sanofi yet.

Sanofi stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a coll…

Full company profile